학술논문

Neoadjuvant Talazoparib in Patients With Germline BRCA1/2 Mutation-Positive, Early-Stage Triple-Negative Breast Cancer: Results of a Phase II Study
Document Type
Article
Source
In: Oncologist. (Oncologist, October 2023, 28(10):845-855)
Subject
Language
English
ISSN
1549490X
10837159